Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
FITC conjugate
Clone:
4G10, monoclonal
Application:
ICC
Citations:
1
biological source
mouse
conjugate
FITC conjugate
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
4G10, monoclonal
species reactivity (predicted by homology)
all
manufacturer/tradename
Upstate®
technique(s)
immunocytochemistry: suitable
isotype
IgG2bκ
shipped in
wet ice
target post-translational modification
phosphorylation (pTyr)
Quality Level
Gene Information
human ... PID1(55022)
General description
Produced from CHO cells expressing the 4G10 antibody heavy and light chain cDNAs. Heavy chain C-terminus has a hexa-histidine tag for purification and immobilization via nickel affinity matrices. Cross-linked to fluorescein isothiocyanate (FITC). Patent pending.
Recognizes: tyrosine-phosphorylated proteins from all species
Molecular Weight: dependent upon the molecular weight of the tyrosine phosphorylated protein being detected
Species Reactivity: wide range
Recognizes: tyrosine-phosphorylated proteins from all species
Molecular Weight: dependent upon the molecular weight of the tyrosine phosphorylated protein being detected
Species Reactivity: wide range
Immunogen
Phosphotyramine-KLH
Application
This Anti-Phosphotyrosine Antibody, recombinant clone 4G10, FITC conjugate is validated for use in IC for the detection of Phosphotyrosine.
Research Category
Signaling
Signaling
Research Sub Category
General Post-translation Modification
General Post-translation Modification
Physical form
100µg FITC-conjugated recombinant mouse IgG2bκ in 67μl of PBS containing 0.05% sodium azide. Liquid at 4°C.
Preparation Note
9 months at 4°C
Analysis Note
routinely evaluated in immunocytochemistry Immunocytochemistry to detect phosphotyrosine-containing proteins in EGF-stimulated human A431 cells
Legal Information
4G10 is a registered trademark of Upstate Group, Inc.
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Bac Viet Le et al.
Cell reports, 33(1), 108221-108221 (2020-10-08)
Synthetic lethality triggered by PARP inhibitor (PARPi) yields promising therapeutic results. Unfortunately, tumor cells acquire PARPi resistance, which is usually associated with the restoration of homologous recombination, loss of PARP1 expression, and/or loss of DNA double-strand break (DSB) end resection
Related Content
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service